Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six-month period without trying, poses a diagnostic challenge in clinical practice. It is often a harbinger of serious underlying conditions, necessitating a comprehensive and systematic approach to its evaluation.
UWL can be attributed to a myriad of causes, including malignancies, gastrointestinal disorders, endocrine abnormalities, psychiatric illnesses, and infections. The initial evaluation should incorporate a detailed history, physical examination, and basic laboratory tests. It is crucial to ascertain the timeline, associated symptoms, and potential risk factors to guide further investigations.
The diagnostic approach to UWL should be patient-centered and guided by clinical judgment. If initial tests are inconclusive, consider targeted investigations based on symptomatology. For instance, imaging studies in the presence of abdominal pain or endocrine tests for symptoms suggestive of hyperthyroidism. Nevertheless, in about 15-25% of cases, the cause remains elusive despite extensive workup.
Management should be tailored to the underlying cause, if identified. In idiopathic UWL, periodic monitoring for the emergence of new symptoms or signs is recommended. Nutritional support and pharmacotherapy may be beneficial in managing symptoms and improving quality of life.
Decoding the cause of UWL requires a meticulous and patient-specific approach, underpinned by a thorough understanding of its diverse etiology. While it can be a diagnostic conundrum, a systematic approach can enhance diagnostic accuracy, facilitate timely management, and ultimately improve patient outcomes. Further research is warranted to refine diagnostic strategies and to elucidate the pathophysiology of idiopathic UWL.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation